SMTL ID : 5lmk.2 (1 other biounit)

Structure of phopsho-CDK2-cyclin A in complex with an ATP-competitive inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 6ZK: 4-[4-[3-bromanyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-5-yl]phenyl]benzamide(Non-covalent)

6ZK.1: 15 residues within 4Å: Chain A: I.11, E.13, V.19, A.32, F.81, E.82, F.83, L.84, H.85, Q.86, D.87, K.90, K.130, Q.132, L.135 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.11, A:F.83, A:Q.132, A:L.135 Hydrogen bonds: A:L.84, A:L.84, A:K.90

1 x SGM: MONOTHIOGLYCEROL(Non-covalent)

SGM.2: 5 residues within 4Å: Chain B: M.15, K.18, C.19, R.67, D.131 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:K.18

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hylsova, M. et al., Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines. Eur J Med Chem (2016)

Release Date

2017-01-25

Peptides

Cyclin-dependent kinase 2: A
Cyclin-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Cyclin-dependent kinase 2

Cyclin-A2

Related Entries With Identical Sequence